UNLABELLED: In elderly man, low serum 25-hydroxyvitamin D (25(OH)D) was associated with a substantial excess risk of death compared to 25(OH)D values greater than 50-70 nmol/l, but the association attenuated with time. INTRODUCTION: The aim of the present study was to determine whether poor vitamin D status was associated with an increase in the risk of death in elderly men. METHODS: We studied the relationship between serum 25(OH)D and the risk of death in 2,878 elderly men drawn from the population and recruited to the MrOS study in Sweden. Baseline data included general health and lifestyle measures and serum 25(OH)D measured by competitive RIA. Men were followed for up to 8.2 years (average 6.0 years). RESULTS: Mortality adjusted for comorbidities decreased by 5% for each SD increase in 25(OH)D overall (gradient of risk 1.05; 95% confidence interval 0.96-1.14). The predictive value of 25(OH)D for death was greatest below a threshold value of 50-70 nmol/l, was greatest at approximately 3 years after baseline and thereafter decreased with time. CONCLUSIONS: Low serum 25(OH)D is associated with a substantial excess risk of death compared to 25(OH)D values greater than 50-70 nmol/l, but the association attenuates with time. These findings, if causally related, have important implications for intervention in elderly men.
UNLABELLED: In elderly man, low serum 25-hydroxyvitamin D (25(OH)D) was associated with a substantial excess risk of death compared to 25(OH)D values greater than 50-70 nmol/l, but the association attenuated with time. INTRODUCTION: The aim of the present study was to determine whether poor vitamin D status was associated with an increase in the risk of death in elderly men. METHODS: We studied the relationship between serum 25(OH)D and the risk of death in 2,878 elderly men drawn from the population and recruited to the MrOS study in Sweden. Baseline data included general health and lifestyle measures and serum 25(OH)D measured by competitive RIA. Men were followed for up to 8.2 years (average 6.0 years). RESULTS: Mortality adjusted for comorbidities decreased by 5% for each SD increase in 25(OH)D overall (gradient of risk 1.05; 95% confidence interval 0.96-1.14). The predictive value of 25(OH)D for death was greatest below a threshold value of 50-70 nmol/l, was greatest at approximately 3 years after baseline and thereafter decreased with time. CONCLUSIONS: Low serum 25(OH)D is associated with a substantial excess risk of death compared to 25(OH)D values greater than 50-70 nmol/l, but the association attenuates with time. These findings, if causally related, have important implications for intervention in elderly men.
Authors: Philip T Liu; Steffen Stenger; Huiying Li; Linda Wenzel; Belinda H Tan; Stephan R Krutzik; Maria Teresa Ochoa; Jürgen Schauber; Kent Wu; Christoph Meinken; Diane L Kamen; Manfred Wagner; Robert Bals; Andreas Steinmeyer; Ulrich Zügel; Richard L Gallo; David Eisenberg; Martin Hewison; Bruce W Hollis; John S Adams; Barry R Bloom; Robert L Modlin Journal: Science Date: 2006-02-23 Impact factor: 47.728
Authors: Eric Orwoll; Janet Babich Blank; Elizabeth Barrett-Connor; Jane Cauley; Steven Cummings; Kristine Ensrud; Cora Lewis; Peggy M Cawthon; Robert Marcus; Lynn M Marshall; Joan McGowan; Kathy Phipps; Sherry Sherman; Marcia L Stefanick; Katie Stone Journal: Contemp Clin Trials Date: 2005-10 Impact factor: 2.226
Authors: Cora E Lewis; Susan K Ewing; Brent C Taylor; James M Shikany; Howard A Fink; Kristine E Ensrud; Elizabeth Barrett-Connor; Steven R Cummings; Eric Orwoll Journal: J Bone Miner Res Date: 2007-02 Impact factor: 6.741
Authors: H Johansson; A Odén; J Kanis; E McCloskey; M Lorentzon; Ö Ljunggren; M K Karlsson; E Orwoll; Å Tivesten; C Ohlsson; D Mellström Journal: Osteoporos Int Date: 2010-06-29 Impact factor: 4.507
Authors: Dan Mellström; Olof Johnell; Osten Ljunggren; Anna-Lena Eriksson; Mattias Lorentzon; Hans Mallmin; Anna Holmberg; Inga Redlund-Johnell; Eric Orwoll; Claes Ohlsson Journal: J Bone Miner Res Date: 2006-04-05 Impact factor: 6.741
Authors: Ilkka Laaksi; Juha-Petri Ruohola; Pentti Tuohimaa; Anssi Auvinen; Riina Haataja; Harri Pihlajamäki; Timo Ylikomi Journal: Am J Clin Nutr Date: 2007-09 Impact factor: 7.045
Authors: Annamari Kilkkinen; Paul Knekt; Antti Aro; Harri Rissanen; Jukka Marniemi; Markku Heliövaara; Olli Impivaara; Antti Reunanen Journal: Am J Epidemiol Date: 2009-09-17 Impact factor: 4.897
Authors: Cedric F Garland; June Jiwon Kim; Sharif Burgette Mohr; Edward Doerr Gorham; William B Grant; Edward L Giovannucci; Leo Baggerly; Heather Hofflich; Joe Wesley Ramsdell; Kenneth Zeng; Robert P Heaney Journal: Am J Public Health Date: 2014-06-12 Impact factor: 9.308
Authors: Ramón A Durazo-Arvizu; Bess Dawson-Hughes; Holly Kramer; Guichan Cao; Joyce Merkel; Paul M Coates; Christopher T Sempos Journal: Am J Epidemiol Date: 2017-04-15 Impact factor: 4.897
Authors: Lisa B Signorello; Xijing Han; Qiuyin Cai; Sarah S Cohen; Elizabeth L Cope; Wei Zheng; William J Blot Journal: Am J Epidemiol Date: 2012-11-01 Impact factor: 4.897
Authors: Christopher T Sempos; Ramón A Durazo-Arvizu; Bess Dawson-Hughes; Elizabeth A Yetley; Anne C Looker; Rosemary L Schleicher; Guichan Cao; Vicki Burt; Holly Kramer; Regan L Bailey; Johanna T Dwyer; Xinli Zhang; Jaime Gahche; Paul M Coates; Mary Frances Picciano Journal: J Clin Endocrinol Metab Date: 2013-05-10 Impact factor: 5.958
Authors: E V McCloskey; J A Kanis; A Odén; N C Harvey; D Bauer; J González-Macias; D Hans; S Kaptoge; M A Krieg; T Kwok; F Marin; A Moayyeri; E Orwoll; C Gluёr; H Johansson Journal: Osteoporos Int Date: 2015-02-18 Impact factor: 4.507
Authors: R Rizzoli; J Branco; M-L Brandi; S Boonen; O Bruyère; P Cacoub; C Cooper; A Diez-Perez; J Duder; R A Fielding; N C Harvey; M Hiligsmann; J A Kanis; J Petermans; J D Ringe; Y Tsouderos; J Weinman; J-Y Reginster Journal: Osteoporos Int Date: 2014-07-15 Impact factor: 4.507
Authors: H Johansson; A Odén; M K Karlsson; E McCloskey; J A Kanis; C Ohlsson; D Mellström Journal: Osteoporos Int Date: 2014-05-09 Impact factor: 4.507